Login / Signup

Ustekinumab for the Treatment of Giant Cell Arteritis.

Mark A MatzaAna D FernandesJohn H StoneSebastian H Unizony
Published in: Arthritis care & research (2021)
UST combined with 24 weeks of prednisone was associated with a high rate of treatment failure in this prospective GCA trial.
Keyphrases
  • giant cell
  • combination therapy
  • preterm birth